Tengion, Inc. is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. The Company, by using its Organ Regeneration Platform, it creates neo-organs using patient's own cells. The Company, based on its clinical and preclinical experience is leveraging its Organ Regeneration Platform to develop Neo-Kidney Augment for patients with advanced chronic kidney disease and Neo-Urinary Conduit for bladder cancer patients who are in need of a urinary diversion. The Company's product candidates are intended to delay or eliminate the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:TNGN
Previous Symbol
CUSIPN/A
Phone+1-336-7225855
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
Tengion (OTCMKTS:TNGN) Frequently Asked Questions
What is Tengion's stock symbol?
Tengion trades on the OTCMKTS under the ticker symbol "TNGN."
Has Tengion been receiving favorable news coverage?
Headlines about TNGN stock have been trending very positive this week, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tengion earned a media sentiment score of 3.9 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future.
Who are Tengion's key executives?
Tengion's management team includes the folowing people:
- David I. Scheer, Independent Chairman of the Board (Age 63)
- Carl-Johan Dalsgaard M.D., Independent Director (Age 56)
- Diane K. Jorkasky M.D., Independent Director (Age 61)
- Richard E. Kuntz M.D., Independent Director (Age 58)
- Lorin Jeffry Randall, Independent Director
How do I buy shares of Tengion?
Shares of TNGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tengion's official website?
How can I contact Tengion?
Tengion's mailing address is 3929 Westpoint Blvd Ste G, WINSTON SALEM, NC 27103-6761, United States. The company can be reached via phone at +1-336-7225855.
MarketBeat Community Rating for Tengion (OTCMKTS TNGN)
MarketBeat's community ratings are surveys of what our community members think about Tengion and other stocks. Vote "Outperform" if you believe TNGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TNGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
